Ofatumumab Shows High Elimination of Disease Activity in MS Ofatumumab Shows High Elimination of Disease Activity in MS

The pooled findings from the phase 3 ASCLEPIOS trials show robust efficacy of the self-injected therapy for relapsing multiple sclerosis.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news